Peri-implant osteonecrosis of the jaw in a patient prescribed selective estrogen receptor modulators

Peri-implant osteonecrosis of the jaw in a patient prescribed selective estrogen receptor modulators

Bibliographic Details
Main Authors:	Tona Yoshino, Keisuke Seki, Maki Nagasaki, Atsushi Kamimoto
Format:	Article
Language:	English
Published:	Elsevier 2023-10-01
Series:	Journal of Dental Sciences
Subjects:	MRONJ Diabetes mellitus Selective estrogen receptor modulator Raloxifene hydrochloride
Online Access:	http://www.sciencedirect.com/science/article/pii/S1991790223001903

Similar Items

Medication-Related Osteonecrosis of the Jaws (MRONJ) in Children and Young Patients—A Systematic Review
by: Hemil Dario Rosales, et al.
Published: (2023-02-01)

Periapical granuloma with actinomycosis and medication-related osteonecrosis of the jaw in a patient prescribed high-dose ibandronate
by: Keisuke Seki, et al.
Published: (2023-04-01)

Medication-Related Osteonecrosis of the Jaw—A Continuing Issue
by: Krzysztof Wróbel, et al.
Published: (2021-08-01)

Role of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ)
by: Yong-Dae Kwon, et al.
Published: (2016-11-01)

Plasma Therapy for Medication-Related Osteonecrosis of the Jaws- A Case Report
by: Maryam Jalili Sadrabad, et al.
Published: (2023-07-01)

Treatment of medication-related osteonecrosis of the jaw with cell therapy
by: Cyril Lucien Bouland, et al.
Published: (2024-01-01)

Medication-Related Osteonecrosis of the Jaws: A Comparison of SICMF–SIPMO and AAOMS Guidelines
by: Davide De Cicco, et al.
Published: (2023-06-01)

The immune activity of selective estrogen receptor modulators is gene and macrophage subtype-specific yet converges on Il1b downregulation
by: Chiara Sfogliarini, et al.
Published: (2023-09-01)

Medication-related osteonecrosis of the jaw after dental clearance: Prevalence in an oncology center
by: Saad Hajeri, BDS, et al.
Published: (2022-09-01)

Intermittent parathyroid hormone enhances the healing of medication-related osteonecrosis of the jaw lesions in rice rats
by: E. J. Castillo, et al.
Published: (2023-06-01)

Correlations between Immune Response and Etiopathogenic Factors of Medication-Related Osteonecrosis of the Jaw in Cancer Patients Treated with Zoledronic Acid
by: George Adrian Ciobanu, et al.
Published: (2023-09-01)

Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ)
by: Sven Otto, et al.
Published: (2021-05-01)

A Multidisciplinary Pathway for the Diagnosis and Prosthodontic Management of a Patient with Medication-Related Osteonecrosis of the Jaw (MRONJ)
by: Amr S. Bugshan, et al.
Published: (2022-08-01)

Clinical values of serum Semaphorin 4D (Sema4D) in medication‑related osteonecrosis of the jaw
by: Hong Mu, et al.
Published: (2023-03-01)

Ultrasonic Navigation for the Treatment of Medication-Related Jaw Osteonecrosis Involving the Inferior Alveolar Nerve: A Case Report and Protocol Review
by: Gerardo Pellegrino, et al.
Published: (2020-10-01)

Non-Interventional Prospective Observational Study of Platelet Rich Fibrin as a Therapy Adjunctive in Patients with Medication-Related Osteonecrosis of the Jaw
by: Sebastian Blatt, et al.
Published: (2022-01-01)

Investigation of the Effectiveness of Surgical Treatment on Maxillary Medication-Related Osteonecrosis of the Jaw: A Literature Review
by: Kun-Jung Hsu, et al.
Published: (2021-09-01)

Peri-implantitis-induced medication-related osteonecrosis of the jaw: A case report
by: Keisuke Seki, et al.
Published: (2022-01-01)

Medication-Related Osteonecrosis of the Jaws Initiated by Zoledronic Acid and Potential Pathophysiology
by: Aya Alsalih, et al.
Published: (2021-07-01)

Nutritional Status in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ)
by: Johannes Laimer, et al.
Published: (2021-05-01)

MicroRNA in medication related osteonecrosis of the jaw: a review
by: Siti Salmiah Mohd Yunus, et al.
Published: (2023-04-01)

Medication-related osteonecrosis of the jaw using periodontitis-induced rat before tooth extraction
by: Kyeong-Mee Park, et al.
Published: (2023-08-01)

Analysis of Factors Associated with the Postoperative Healing of Medication-Related Osteonecrosis of the Jaw in Patients with Osteoporosis
by: Young-Ho Shim, et al.
Published: (2021-08-01)

Schemes for Drug-Induced Treatment of Osteonecrosis of Jaws with Particular Emphasis on the Influence of Vitamin D on Therapeutic Effects
by: Filip Michalak, et al.
Published: (2021-03-01)

Resective Surgery versus Debridement in Stage 2 Medication-Related Osteonecrosis of the Jaw
by: Salvatore D’Amato, et al.
Published: (2021-09-01)

Medication-Related Osteonecrosis of the Jaw (MRONJ): Are Antiresorptive Drugs the Main Culprits or Only Accomplices? The Triggering Role of Vitamin D Deficiency
by: Luca Dalle Carbonare, et al.
Published: (2021-02-01)

The Importance of Alliance between Hematologists and Dentists: A Retrospective Study on the Development of Bisphosphonates Osteonecrosis of the Jaws (Bronj) in Multiple Myeloma Patients
by: Christian Bacci, et al.
Published: (2021-01-01)

Role of preoperative SPECT/CT standardized uptake values in medication-related osteonecrosis of the jaw: a preliminary study of SPECT/CT in relation to cone-beam CT and histopathological findings of the resected bone of mandibulectomy
by: Eizaburo Kobayashi, et al.
Published: (2023-06-01)

Autologous Platelet-Rich Fibrin (PRF) as an Adjunct in the Management of Osteoradionecrosis and Medication-Related Osteonecrosis of Jaws. Case Series in A Single Centre
by: Benjie Law, et al.
Published: (2021-04-01)

Prediction of medication-related osteonecrosis of the jaws using machine learning methods from estrogen receptor 1 polymorphisms and clinical information
by: Seo-Yong Choi, et al.
Published: (2023-06-01)

The use of advanced‐platelet rich fibrin (A‐PRF) in the management of medication‐related osteonecrosis of the jaw (MRONJ): A case report
by: Maan Ahmad Rafik Asfour, et al.
Published: (2023-11-01)

Current Trends in Adjuvant Therapies for Medication-Related Osteonecrosis of the Jaw
by: Gyu-Jo Shim, et al.
Published: (2022-04-01)

Location and Gender Differences in Osteonecrosis of the Jaws in Patients Treated with Antiresorptive and Antineoplastic Drugs Undergoing Dentoalveolar Surgical, Systematic Review with Meta-Analysis and Trial Sequential Analysis
by: Mario Dioguardi, et al.
Published: (2023-05-01)

Influence of Resveratrol Against Ovariectomy Induced Bone Loss in Rats: Comparison With Conjugated Equine Estrogen Tibolone and Raloxifene
by: Ömer Çelik, et al.
Published: (2007-08-01)

A Comprehensive Quality Meta-Review of Genetic and Pharmacogenomic Aspects of Medication-Related Osteonecrosis of The Jaw (MRONJ)
by: Roberto Sacco, et al.
Published: (2022-12-01)

Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ) with Er:YaG Laser and Ozone Therapy: A Case Series
by: Gianluca Porcaro, et al.
Published: (2022-10-01)

Evaluation of Medication-Related Osteonecrosis of the Jaw (MRONJ) in Terms of Staging and Treatment Strategies by Dental Students at Different Educational Levels
by: Diana Heimes, et al.
Published: (2023-01-01)

Outcomes of a Pharmacological Protocol with Pentoxifylline and Tocopherol for the Management of Medication-Related Osteonecrosis of the Jaws (MRONJ): A Randomized Study on 202 Osteoporosis Patients
by: Gianluca Colapinto, et al.
Published: (2023-07-01)

Relationship between Medication-Related Osteonecrosis of the Jaw and CDK4/6 Inhibitors in Breast Cancer
by: Loreto Domínguez Senín, et al.
Published: (2024-01-01)

Radiological manifestations and clinical findings of patients with oncologic and osteoporotic medication-related osteonecrosis of the jaw
by: Jeong Won Shin, et al.
Published: (2024-04-01)